Second Version of Generic Wellbutrin Pulled Out by FDA

Sunday, November 3rd, 2013

The United States Food and Drug Administration (FDA) recently announced that a second version of generic Wellbutrin XL 300mg is to be pulled from the market. The reason for this decision was that the drug was not found to be a bioequivalent to GlaxoSmithKline’s original branded drug. The generic drug in question was marketed as […]

Wellbutrin Approval for Jubilant Life Sciences

Friday, October 25th, 2013

Jubilant Life Sciences, a pharmaceutical company, recently announced that the United States Food and Drug Administration (FDA) gave Abbreviated New Drug Application (ANDA) approval to its bupropion medication. The approval has been given for extended-release tablets of bupropion, which is the generic version of Wellbutrin, manufactured by GlaxoSmithKline. The FDA also approved Jubilant Life Science’s […]